Roche announced a $50 billion investment in the U.S. over the next five years, according to CNBC. The move aims to expand its manufacturing and R&D footprint amid tariff threats from President Donald Trump. The Swiss pharmaceutical company said its investment will create over 12,000 jobs, including 1,000 within the company and the rest tied to expanded U.S. manufacturing. The investment includes new facilities in Indiana, Pennsylvania, Massachusetts, and California, as well as a new manufacturing center to support its next-gen weight loss treatments.
